Quick Look: Perficient’s stock soared after an analyst upgrade and acquisition news,
Quick Look: Perficient’s stock soared after an analyst upgrade and acquisition news, peaking at $73.70. Multiple analysts upgraded Perficient, with targets ranging from $59 to $77. EQT AB announced its acquisition of Perficient for
Quick Look: Sunrun’s stock up by 4.7% recently, despite past volatility and a 12-month high of $23.85. Q1 earnings report showed a significant loss (EPS of -$1.33) but exceeded revenue expectations. Analysts maintain a ‘Moderate Buy’ with a future
Quick Look: U.S. stocks show slight gains as investors seek recovery from last week’s losses, with the Dow Jones up by 10 points. Market volatility was highlighted by significant downturns last week, including a 2.3% drop in the Dow
Quick Look: Dow Jones futures remain stable, while S&P 500 futures dip and Nasdaq futures rise, indicating mixed market sentiment. Upcoming earnings reports from major banks and companies like Delta Air Lines spotlight corporate health amidst economic uncertainty. This
Quick Look: Staar Surgical’s Q1 revenue hit $77 million, surpassing the expected $72 million. Evo implantable lens sales in the U.S. reached $5 million, exceeding projections. The stock price soared by 16.5%, indicating strong investor confidence. Staar sets a
Asian equities fell during the afternoon trade on Wednesday, with Hong Kong’s Hang Seng plummeting 3 percent, as weaker-than-expected Caixin PMI data dampened investors’ sentiment. Read more here!
US stock futures slipped and Asian shares stumbled on Thursday after a rare revenue warning from Apple Inc added to worries about slowing global growth and weaker earnings and jolted currency markets. Read more here!
US stocks were lower after the close on Thursday night, with losses in the Technology, Industrial, and Basic Materials sectors led the shares lower. Read more here!
Asian stocks rallied on Monday as a dovish turn by the Federal Reserve and unexpectedly strong US jobs data soothed some of the market’s worst fears about the global outlook. Read more here!
Quick Look: Perficient’s stock soared after an analyst upgrade and acquisition news, peaking at $73.70. Multiple analysts upgraded Perficient, with targets ranging from $59 to $77. EQT AB announced its acquisition of Perficient for $3 billion, offering $76 per share. Notable insider sales and strong institutional interest were observed.
Quick Look: Sunrun’s stock up by 4.7% recently, despite past volatility and a 12-month high of $23.85. Q1 earnings report showed a significant loss (EPS of -$1.33) but exceeded revenue expectations. Analysts maintain a ‘Moderate Buy’ with a future target of $22.05 amidst market turbulence. Core focus on
Quick Look: U.S. stocks show slight gains as investors seek recovery from last week’s losses, with the Dow Jones up by 10 points. Market volatility was highlighted by significant downturns last week, including a 2.3% drop in the Dow Jones. Analysts emphasise the importance of upcoming inflation data
Quick Look: Dow Jones futures remain stable, while S&P 500 futures dip and Nasdaq futures rise, indicating mixed market sentiment. Upcoming earnings reports from major banks and companies like Delta Air Lines spotlight corporate health amidst economic uncertainty. This week’s economic events and inflation data are critical for
Quick Look: Staar Surgical’s Q1 revenue hit $77 million, surpassing the expected $72 million. Evo implantable lens sales in the U.S. reached $5 million, exceeding projections. The stock price soared by 16.5%, indicating strong investor confidence. Staar sets a sales forecast of $335 million to $340 million for
Quick Look: Perficient’s stock soared after an analyst upgrade and acquisition news, peaking at $73.70. Multiple analysts upgraded Perficient, with targets ranging from $59 to $77. EQT AB announced its acquisition of Perficient for